THC Biomed Intl Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
John Miller
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 9.1yrs |
| Eigendom CEO | 19.1% |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | 8.8yrs |
Recente managementupdates
Recent updates
Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?
Oct 11
Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?
Jun 26Is THC Biomed Intl (CSE:THC) Weighed On By Its Debt Load?
Mar 13Is THC Biomed Intl (CSE:THC) Using Too Much Debt?
Aug 30We Think THC Biomed Intl (CSE:THC) Has A Fair Chunk Of Debt
Mar 25Does THC Biomed Intl (CSE:THC) Have A Healthy Balance Sheet?
Dec 02Is THC Biomed Intl (CSE:THC) Using Too Much Debt?
Jun 01Analysts Expect Breakeven For THC Biomed Intl Ltd. (CSE:THC) Before Long
Apr 06Would THC Biomed Intl (CSE:THC) Be Better Off With Less Debt?
Jan 08Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Apr 30 2023 | n/a | n/a | -CA$4m |
| Jan 31 2023 | n/a | n/a | -CA$3m |
| Oct 31 2022 | n/a | n/a | -CA$3m |
| Jul 31 2022 | n/a | n/a | -CA$3m |
| Apr 30 2022 | n/a | n/a | -CA$3m |
| Jan 31 2022 | n/a | n/a | -CA$4m |
| Oct 31 2021 | n/a | n/a | -CA$6m |
| Jul 31 2021 | n/a | n/a | -CA$6m |
| Apr 30 2021 | n/a | n/a | -CA$6m |
| Jan 31 2021 | n/a | n/a | -CA$5m |
| Oct 31 2020 | n/a | n/a | -CA$2m |
| Jul 31 2020 | n/a | n/a | -CA$162k |
| Apr 30 2020 | n/a | n/a | -CA$4m |
| Jan 31 2020 | n/a | n/a | -CA$8m |
| Oct 31 2019 | n/a | n/a | -CA$13m |
| Jul 31 2019 | CA$67k | CA$60k | -CA$13m |
| Apr 30 2019 | n/a | n/a | -CA$12m |
| Jan 31 2019 | n/a | n/a | -CA$7m |
| Oct 31 2018 | n/a | n/a | -CA$12m |
| Jul 31 2018 | CA$67k | n/a | -CA$12m |
| Apr 30 2018 | n/a | n/a | -CA$10m |
| Jan 31 2018 | n/a | n/a | -CA$11m |
| Oct 31 2017 | n/a | n/a | -CA$1m |
| Jul 31 2017 | CA$66k | CA$60k | -CA$605k |
Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van John redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de Canadian markt.
Compensatie versus inkomsten: De vergoeding van John is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
John Miller
9.1yrs
Tenure
CA$66,750
Compensatie
Mr. John Miller serves as Chief Executive Officer at THC Biomed Intl Ltd. since April 29, 2015. He is also President at THC Biomed Intl Ltd.and its Director since June 3, 2014. He was Director and Office...
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 9.9yrs | CA$66.75k | 19.14% CA$ 627.5k | |
| Co-Founder | 9.9yrs | CA$66.66k | 9.89% CA$ 324.2k | |
| Member of Advisory Board | 8.8yrs | geen gegevens | geen gegevens | |
| Member of Advisory Board | 8.8yrs | geen gegevens | geen gegevens | |
| Independent Director | 6.9yrs | CA$6.50k | geen gegevens | |
| Independent Director | 4.2yrs | geen gegevens | 0.0061% CA$ 200.0 |
8.8yrs
Gemiddelde duur
Ervaren bestuur: De raad van bestuur van THC wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.8 jaar).